Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 10,353 | 4,358 | 5,085 | 49,440 | 6,008 |
| Gross Profit | 10,353 | 4,358 | 5,085 | 49,440 | 6,008 |
| Operating Expenses | 39,680 | 33,939 | 28,944 | 29,054 | 28,131 |
| Operating Income | -29,327 | -29,581 | -23,859 | 20,386 | -22,123 |
| Interest Expense | 689 | 700 | 700 | 695 | 548 |
| Other Income | 305 | 405 | 499 | 576 | 984 |
| Pre-tax Income | -29,711 | -29,876 | -24,060 | 20,267 | -21,687 |
| Net Income Continuous | -29,711 | -29,876 | -24,060 | 20,267 | -21,687 |
| Net Income | $-29,711 | $-29,876 | $-24,060 | $20,267 | $-21,687 |
| EPS Basic Total Ops | -0.43 | -0.46 | -0.35 | 0.32 | -0.35 |
| EPS Basic Continuous Ops | -0.43 | -0.46 | -0.35 | 0.32 | -0.35 |
| EPS Diluted Total Ops | -0.43 | -0.43 | -0.35 | 0.29 | -0.35 |
| EPS Diluted Continuous Ops | -0.43 | -0.43 | -0.35 | 0.29 | -0.35 |
| EPS Diluted Before Non-Recurring Items | -0.43 | -0.43 | N/A | N/A | N/A |
| EBITDA(a) | $-29,210 | $-30,588 | $-23,025 | $20,916 | $-21,683 |